豆紋動(dòng)脈區(qū)分支動(dòng)脈粥樣硬化病和腔隙性腦梗死早期神經(jīng)惡化的臨床研究
發(fā)布時(shí)間:2018-08-30 20:40
【摘要】:目的:探討豆紋動(dòng)脈區(qū)(LSA)分支動(dòng)脈粥樣硬化疾病(BAD)和腔隙性腦梗死(LI)早期神經(jīng)惡化(END)危險(xiǎn)因素及預(yù)后。方法:收集2013年03月至2016年10月期間住院,經(jīng)頭顱MRI檢查證實(shí)存在LSA急性腦梗死患者76例。按頭顱MRI結(jié)果分為BAD組(40例),LI組(36例)。入院72 h內(nèi)根據(jù)美國國立衛(wèi)生研究院卒中量表(NIHSS)評(píng)分變化劃分為END組(28例),非END組(48例)。收集基線資料、臨床資料,進(jìn)行比較。結(jié)果:(1)BAD組糖尿病史、HbA1C、Hcy、入院時(shí)NIHSS、偏癱發(fā)生率、發(fā)病1個(gè)月mRS評(píng)分均顯著高于LI組;(2)發(fā)病3個(gè)月mRS評(píng)分BAD組與LI組之間無顯著性差異;(3)BAD組與LI組比較更易發(fā)生END;(4)BAD組中END患者糖尿病史、HbA1C、Hcy、入院時(shí)NIHSS、發(fā)病1個(gè)月mRS評(píng)分均高于非END患者;(5)多因素Logistic回歸分析示HbA1C、Hcy是BAD組END的危險(xiǎn)因素。結(jié)論:LSA供血區(qū)BAD患者病情重,易進(jìn)展,HbA1C、Hcy是END的危險(xiǎn)因素;BAD組及LI組患者3個(gè)月預(yù)后均較好。
[Abstract]:Objective: to investigate the risk factors and prognosis of early nerve deterioration (END) in patients with (LSA) branch atherosclerosis and lacunar cerebral infarction (LI). Methods: from March 2013 to October 2016, 76 patients with acute cerebral infarction of LSA were confirmed by cranial MRI examination. According to the results of cranial MRI, the patients were divided into BAD group (40 cases) and Li group (36 cases). Within 72 hours of admission, the patients were divided into END group (28 cases) and non-END group (48 cases) according to the changes of (NIHSS) score of stroke scale of the National Institutes of Health. The baseline data and clinical data were collected and compared. Results: (1) in BAD group, the history of diabetes mellitus and the incidence of NIHSS, hemiplegia were observed. (2) there was no significant difference in mRS score between BAD group and LI group at 3 months after onset, (3) END; (4) BAD group and LI group were more likely to develop HbA1CU HcyA in END group, and mRS evaluation on NIHSS, 1 month after hospitalization in END; (4) BAD group was more likely to occur in END; (4) BAD group than in END; (4) BAD group. (5) multivariate Logistic regression analysis showed that HbA1C,Hcy was the risk factor of END in BAD group. Conclusion the patients with BAD in the blood supply area of W1 LSA are in a serious condition, and HbA1C- Hcy is a risk factor for END. The prognosis of patients in bad group and LI group is better than that in LI group in 3 months.
【作者單位】: 江蘇省連云港市第二人民醫(yī)院神經(jīng)內(nèi)科;
【基金】:連云港市“科教興衛(wèi)工程”青年科技項(xiàng)目(QN1408)
【分類號(hào)】:R743.33
本文編號(hào):2214229
[Abstract]:Objective: to investigate the risk factors and prognosis of early nerve deterioration (END) in patients with (LSA) branch atherosclerosis and lacunar cerebral infarction (LI). Methods: from March 2013 to October 2016, 76 patients with acute cerebral infarction of LSA were confirmed by cranial MRI examination. According to the results of cranial MRI, the patients were divided into BAD group (40 cases) and Li group (36 cases). Within 72 hours of admission, the patients were divided into END group (28 cases) and non-END group (48 cases) according to the changes of (NIHSS) score of stroke scale of the National Institutes of Health. The baseline data and clinical data were collected and compared. Results: (1) in BAD group, the history of diabetes mellitus and the incidence of NIHSS, hemiplegia were observed. (2) there was no significant difference in mRS score between BAD group and LI group at 3 months after onset, (3) END; (4) BAD group and LI group were more likely to develop HbA1CU HcyA in END group, and mRS evaluation on NIHSS, 1 month after hospitalization in END; (4) BAD group was more likely to occur in END; (4) BAD group than in END; (4) BAD group. (5) multivariate Logistic regression analysis showed that HbA1C,Hcy was the risk factor of END in BAD group. Conclusion the patients with BAD in the blood supply area of W1 LSA are in a serious condition, and HbA1C- Hcy is a risk factor for END. The prognosis of patients in bad group and LI group is better than that in LI group in 3 months.
【作者單位】: 江蘇省連云港市第二人民醫(yī)院神經(jīng)內(nèi)科;
【基金】:連云港市“科教興衛(wèi)工程”青年科技項(xiàng)目(QN1408)
【分類號(hào)】:R743.33
【相似文獻(xiàn)】
相關(guān)期刊論文 前5條
1 楊任民;徐銀;;分支動(dòng)脈粥樣硬化病附3例報(bào)告及文獻(xiàn)復(fù)習(xí)[J];中國臨床神經(jīng)科學(xué);2010年04期
2 孟慶芳;陳慶華;梁濤;胡西;;高壓氧聯(lián)合腦蛋白水解物加康復(fù)療法治療急性腦梗死[J];實(shí)用醫(yī)藥雜志;2014年04期
3 譚仁江;;疏血通注射液聯(lián)合丁苯酞治療急性進(jìn)展性腦梗死療效觀察[J];中醫(yī)藥臨床雜志;2014年05期
4 張輝;;補(bǔ)陽還五湯配合常規(guī)治療氣虛血瘀型腦梗死臨床回顧性研究[J];中醫(yī)藥臨床雜志;2014年05期
5 羅鴻波;陳菱菱;李麗萍;;依達(dá)拉奉聯(lián)合丁苯酞治療腦梗死療效觀察[J];當(dāng)代醫(yī)學(xué);2014年12期
相關(guān)博士學(xué)位論文 前1條
1 梅斌;分支動(dòng)脈粥樣硬化病CISS亞型臨床差異性研究[D];武漢大學(xué);2016年
相關(guān)碩士學(xué)位論文 前1條
1 劉彤彤;椎動(dòng)脈優(yōu)勢與后循環(huán)缺血性卒中及椎動(dòng)脈、鎖骨下動(dòng)脈粥樣硬化的關(guān)系[D];大連醫(yī)科大學(xué);2015年
,本文編號(hào):2214229
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2214229.html
最近更新
教材專著